Hepatology Research Faculty

The UC Davis Division of Gastroenterology and Hepatology is one of the West Coast’s premier research institutions for diseases of the liver and gastrointestinal tract. Our research program is truly translational, with programs that reach from bench to bedside. We offer a multitude of clinical trials and observational studies to further our understanding of disease, help discover new treatments, and provide cutting-edge care for our patients. Funding for our research is provided by the National Institute for Health (NIH), the Center for Disease Control and Prevention (CDC), pharmaceutical industry partners, and UC Davis Health.

Some of our current research projects include investigating: 

  • Basic molecular pathways of fibrosis, particularly in the setting of nonalcoholic steatohepatitis (NASH)
  • Impact of prenatal diet on clinical severity of Wilson disease and its implications on NASH and alcoholic liver disease
  • Genetic and immunologic basis of primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC)
  • Development of novel imaging technologies to diagnose NASH non-invasively
  • Use of technology to better manage ascites and other complications of cirrhosis
  • Effects of community engagement, patient education and physician-based interventions to improve hepatitis B testing among Asian Americans

The Gastroenterology Clinical Trials Unit is conveniently located just a few blocks from the UC Davis Medical Center in the Ticon I building. The facility is close to US-50 and I-80 and provides free on-site parking. Our research team includes faculty physicians, clinical research coordinators, analysts, and students.

Click here to find current trials open for recruitment at UC Davis.

At UC Davis, our mission is to provide a welcoming environment, design individualized care, and conduct ethical research. All studies are reviewed and approved by the UC Davis Institutional Review Board (IRB) and conducted according to Good Clinical Practice Guidelines.